This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Illumina Inc. shed 4.7% to $74.53 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.8% to 5,606.91 and Dow Jones Industrial Average falling 0.9% to 40,829.00.
The stock's fall snapped a two-day winning streak.
Illumina Inc. closed 52.4% short of its 52-week high of $156.66, which the company reached on November 5th.
The stock underperformed when compared to some of its competitors, as Labcorp Holdings Inc. fell 1.2% to $243.92, Charles River Laboratories International Inc. fell 3.4% to $115.41, and Quest Diagnostics Inc. fell 0.82% to $176.11.
Trading volume totaled 1.7 million, compared to the 50-day average of 2.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。